Maternal and infant outcomes following third trimester exposure to marijuana in opioid dependent pregnant women maintained on buprenorphine

•Prenatal marijuana exposure does not appear to impact pregnancy or delivery.•Prenatal marijuana exposure may increase likelihood of treatment for neonatal abstinence syndrome (NAS).•Prenatal marijuana exposure may lengthen duration of infant hospitalization. To determine whether maternal and infant...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Drug and alcohol dependence 2017-11, Vol.180, p.200-203
Hauptverfasser:	O’Connor, Alane B., Kelly, Brandon K., O’Brien, Liam M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Analgesics, Opioid - therapeutic use Apgar score Babies Birth Weight Buprenorphine Buprenorphine - administration & dosage Buprenorphine - therapeutic use Cannabis Cohort analysis Exposure Female Gestational Age Hospitalization Humans Infant Infant, Newborn Infants Length of Stay Marijuana Marijuana Smoking Narcotics Neonatal abstinence syndrome Neonatal Abstinence Syndrome - drug therapy Neonatal Abstinence Syndrome - epidemiology Neonates Opioid use disorders Opioid-Related Disorders - drug therapy Opioid-Related Disorders - epidemiology Opioids Pharmacology Postpartum period Pregnancy Pregnancy Complications - drug therapy Pregnancy Complications - epidemiology Pregnancy Trimester, Third Prenatal care Prenatal experience Prenatal exposure Retrospective Studies Severity Substance Withdrawal Syndrome - drug therapy
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!